Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
Add more filters










Database
Publication year range
1.
Int J Mol Sci ; 23(21)2022 Nov 01.
Article in English | MEDLINE | ID: mdl-36362149

ABSTRACT

Because ceramide-like lipo-amino acid cholesteryl derivatives can exert a bound water-holding function due to their lamellae-forming properties, in this study, we determined if topical application of those derivatives to atopic dry skin would elicit an ameliorative effect on skin symptoms, at least on its water-holding function. In this clinical study, daily treatment with a nano-emulsion containing 10% phytosteryl/octyldodecyl lauroyl glutamate (POLG) significantly (p < 0.0001) improved skin symptoms, including dryness/scaling, itchiness and stimulus sensations, in the non-lesional skin of patients with atopic dermatitis (AD) at 3 and at 6 weeks compared with week 0. Those significant improvements in skin symptoms were accompanied by a significantly enhanced water content (conductance) and a significant improvement of roughness (SESC) and smoothness (SESM) values measured using a Visioscan at 3 and 6 weeks. Those effects appeared concomitant with a significantly increased corneocyte size, a significantly down-regulated degree of thick abrasions, and a significant impairment of the corneocyte lipid envelope at 6 weeks. Thus, our clinical study suggests, for the first time, that topical application of the POLG nano-emulsion has the distinct potential to ameliorate atopic dry skin symptoms, particularly scaling and itchiness, in the skin of patients with AD. Those effects result from alleviation of the disrupted water-holding function probably due to the increased supply of lamellae structures into the stratum corneum despite the failure to improve barrier function.


Subject(s)
Dermatitis, Atopic , Skin Diseases , Humans , Dermatitis, Atopic/etiology , Ceramides/metabolism , Water/metabolism , Epidermis/metabolism , Skin/metabolism , Skin Diseases/metabolism , Emulsions/metabolism , Organic Chemicals/metabolism , Amino Acids/metabolism
2.
J Cosmet Dermatol ; 21(11): 5747-5754, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35778882

ABSTRACT

OBJECTIVES: To evaluate the moisturizing function and other effects of royal jelly extract on the skin. The effects of applying an essence containing royal jelly extract on the skin of healthy Japanese males and females were examined. METHODS: Thirty-five healthy Japanese men and women who were aware of their skin dryness applied an essence containing royal jelly extract or placebo for 4 weeks using the split-face method in a placebo-controlled, double-blind, parallel comparative study. The stratum corneum water content, transepidermal water evaporation, pigmentation, pores, and redness were evaluated. RESULTS: The stratum corneum water content significantly increased by the application of essence containing royal jelly extract to the cheeks for 4 weeks compared with placebo. CONCLUSION: The application of an essence containing royal jelly extract significantly improved the moisture content of the stratum corneum of the cheeks, confirming the improvement in the moisturizing function of the royal jelly extract. Furthermore, no adverse events were observed at the application site during the application period, and the test products and royal jelly extract contained in the test product were considered highly safe.


Subject(s)
Epidermis , Skin , Female , Humans , Male , Double-Blind Method , Plant Extracts/pharmacology , Water/pharmacology
3.
J Cosmet Dermatol ; 20(6): 1915-1922, 2021 Jun.
Article in English | MEDLINE | ID: mdl-33040474

ABSTRACT

BACKGROUND: Many patients with atopic dermatitis (AD) know that harsh rubbing of their skin might worsen their skin symptoms. They consider that the force they use to rub their skin when removing their makeup cosmetics should not be hard and their cleansing habits could worsen their skin symptoms. However, we presume that the force they use to rub their skin may still be strong and might worsen their skin symptoms. AIMS: We characterized the effects of rubbing the skin of AD patients during cleansing of makeup cosmetics. PATIENTS/METHODS: A cleansing oil which has a higher cleansing ability compared the cleansers used daily by the subjects but required less rubbing force was used. We performed a 4-week clinical trial of this cleansing oil on 35 female subjects who had mild AD skin symptoms on their faces. Each subject used the cleansing oil instead of their usual makeup remover without changing their other facial skin care habits. Prior to the study, and at the end of weeks 1 and 4, the skin conditions of each subject were evaluated. RESULTS: Four weeks of usage of this cleansing oil significantly decreased skin dryness, scaling, irritation, erythema, and itchiness. Higher improvements were observed for subjects who had previously used cleansers with less cleansing ability. Accompanying those improvements, a significant increase in moisture-retention ability and a significant decrease in transepidermal water loss were observed. CONCLUSION: These results suggest that many AD patients cleanse their face with hard rubbing of their skin because of the low cleansing ability of their skin cleansers and may worsen their AD skin symptoms without realizing it.


Subject(s)
Cosmetics , Dermatitis, Atopic , Cosmetics/adverse effects , Emollients , Female , Humans , Skin , Skin Care
4.
Arch Dermatol Res ; 311(3): 183-191, 2019 Apr.
Article in English | MEDLINE | ID: mdl-30778667

ABSTRACT

Little is known about the anti-pigmenting effects of whitening agents on solar lentigos (SLs), which comprise ~ 60% of hyperpigmented facial lesions of Asian subjects. Lotions with or without 6% L-ascorbate-2-phosphate trisodium salt (APS) [test lotion (TL) and placebo lotion (PL), respectively] were applied twice daily for 24 weeks in a double-blind half-face study of 27 Japanese females with SLs on both sides of their faces. Pigmentation scores were evaluated using a photo-scale and the skin colors were assessed using a color difference meter and a mexameter for SLs and the non-lesional surrounding skin (NLS). Although the pigmentation scores were not significantly different between the TL and PL-treated SLs after 24 weeks, the L values of TL-treated SLs and NLS increased significantly with a significantly higher △L value in SLs than in NLS. In contrast, the L values of PL-treated SLs and NLS remained unchanged after the treatment. The number of subjects with > 2.0 △L was 7 of 27 (TL) and 0 of 27 (PL) in SLs and 3 of 27 (TL) and 0 of 27 (PS) in NLS. In contrast, the melanin index in TL-treated SLs and NLS significantly decreased with a significantly higher △melanin index in SLs than in NLS. Similarly, the melanin index of PL-treated SLs and NLS were significantly decreased with a significantly higher △melanin index in SLs than in NLS. These findings strongly indicate that APS has a weak but significant anti-pigmenting effect on SLs and a significant whitening effect even on normally pigmented healthy skin.


Subject(s)
Ascorbic Acid/analogs & derivatives , Lentigo/drug therapy , Melanins/metabolism , Melanocytes/drug effects , Skin Lightening Preparations/administration & dosage , Skin Pigmentation/drug effects , Administration, Cutaneous , Ascorbic Acid/administration & dosage , Ascorbic Acid/adverse effects , Asian People , Double-Blind Method , Female , Humans , Japan , Lentigo/diagnosis , Lentigo/ethnology , Lentigo/metabolism , Melanocytes/metabolism , Melanocytes/pathology , Skin Lightening Preparations/adverse effects , Time Factors , Treatment Outcome
5.
Laser Ther ; 23(1): 49-60, 2014 Mar 27.
Article in English | MEDLINE | ID: mdl-24771971

ABSTRACT

BACKGROUND: Tremendous advances have been made in the medical application of the laser in the past few decades. Many diseases in the dermatological field are now indications for laser treatment that qualify for reimbursement by many national health insurance systems. Among laser types, the carbon dioxide (CO2) laser remains an important system for the dermatologist. RATIONALE: The lasers used in photosurgery have wavelengths that differ according to their intended use and are of various types, but the CO2 laser is one of the most widely used lasers in the dermatology field. With its wavelength in the mid-infrared at 10,600 nm, CO2 laser energy is wellabsorbed in water. As skin contains a very high water percentage, this makes the CO2 laser ideal for precise, safe ablation with good hemostasis. In addition to its efficacy in ablating benign raised lesions, the CO2 laser has been reported to be effective in the field of esthetic dermatology in the revision of acne scars as well as in photorejuvenation. With the addition of fractionation of the beam of energy into myriad microbeams, the fractional CO2 laser has offered a bridge between the frankly full ablative indications and the nonablative skin rejuvenation systems of the 2000s in the rejuvenation of photoaged skin on and off the face. CONCLUSIONS: The CO2 laser remains an efficient, precise and safe system for the dermatologist. Technological advances in CO2 laser construction have meant smaller spot sizes and greater precision for laser surgery, and more flexibility in tip sizes and protocols for fractional CO2 laser treatment. The range of dermatological applications of the CO2 laser is expected to continue to increase in the future.

6.
J Cosmet Laser Ther ; 12(1): 21-4, 2010 Feb.
Article in English | MEDLINE | ID: mdl-19929289

ABSTRACT

Chemical peeling of the skin is commonly used as a means to treat photoaging, but the mechanism underlying its efficacy has not yet been fully clarified. We recently conducted chemical peeling of the skin with glycolic acid and lactic acid and observed it at the ultrastructural level. No changes in the horny layer or the upper epidermal layer were observed but there was dissociation and vacuolation between the basal cells and increases in vimentin filaments within fibroblasts and endothelial cells were seen. These findings suggest that chemical peeling of the skin with this type of agent directly induces collagen formation within the dermis and thus directly stimulates remodeling of the dermis.


Subject(s)
Chemexfoliation , Glycolates/therapeutic use , Lactic Acid/therapeutic use , Skin/drug effects , Skin/ultrastructure , Adult , Collagen/biosynthesis , Humans , Male , Skin/metabolism
7.
Arerugi ; 52(11): 1065-73, 2003 Nov.
Article in Japanese | MEDLINE | ID: mdl-14685038

ABSTRACT

The Th2 cytokine inhibitor, suplatast tosilate (300 mg/day) was administered to 45 cases of patients with atopic dermatitis for 8 weeks. The clinical scores, peripheral blood eosinophil counts, serum LDH levels, total IgE levels, serum eosinophil cationic protein (ECP) levels, and serum IL-5 levels before and after the treatment were observed and comparatively evaluated. The results of this study were summarized as follows. 1) Temporary improvements were found in the severity score, itching score, and sleeplessness score. All evaluated scores decreased significantly for all observation periods at 2, 4, 6 and 8 weeks after administration of suplatast tosilate compared with those before the administration. 2) In severe group, there was a significant improvement of severity score of lower limb. In moderate group there were significant improvements of severity score of head, face, neck and of upper limb. There were significant improvements of severity score of trunk and upper limbs in mild group. 3) The peripheral blood eosinophil counts and serum LDH levels significantly diminished compared with those before administration, but no significant difference was found in total IgE levels and serum ECP levels. 4) The serum IL-5 levels decreased after administration, however, there was no statistical significance. 5) The positive correlations between delta-severity score and delta-peripheral eosinophil count, delta-serum LDH levels, delta-serum ECP levels were found. 6) The positive correlations between delta-peripheral eosinophil count and delta-serum LDH levels, delta-serum ECP levels were observed. 7) There was no sign of adverse effects of the drug. From the above mentioned results, we confirmed the high efficacy of suplatast tosilate in the treatment of atopic dermatitis.


Subject(s)
Anti-Allergic Agents/pharmacology , Arylsulfonates/pharmacology , Dermatitis, Atopic/drug therapy , Sulfonium Compounds/pharmacology , Adult , Anti-Allergic Agents/therapeutic use , Arylsulfonates/therapeutic use , Blood Proteins , Dermatitis, Atopic/immunology , Eosinophil Granule Proteins , Eosinophils , Female , Humans , Immunoglobulin E/blood , Interleukin-5/blood , L-Lactate Dehydrogenase/blood , Leukocyte Count , Male , Ribonucleases/blood , Sulfonium Compounds/therapeutic use , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL
...